ArticleCancers2023

BR109, a Novel Fully Humanized T-Cell-Engaging Bispecific Antibody with GPRC5D Binding, Has Potent Antitumor Activities in Multiple Myeloma.

Ying Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.